Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Extracellular vesicles in Alzheimer's disease: from pathology to therapeutic approaches.

Extracellular vesicles in Alzheimer's disease: from pathology to therapeutic approaches. Neural regeneration research Garcia-Contreras, M., Thakor, A. S. 2023; 18 (1): 18-22

Abstract

Alzheimer's disease is a progressive and fatal neurodegenerative disorder that starts many years before the onset of cognitive symptoms. Identifying novel biomarkers for Alzheimer's disease has the potential for patient risk stratification, early diagnosis, and disease monitoring in response to therapy. A novel class of biomarkers is extracellular vesicles given their sensitivity and specificity to specific diseases. In addition, extracellular vesicles can be used as novel biological therapeutics given their ability to efficiently and functionally deliver therapeutic cargo. This is critical given the huge unmet need for novel treatment strategies for Alzheimer's disease. This review summarizes and discusses the most recent findings in this field.

View details for DOI 10.4103/1673-5374.343882

View details for PubMedID 35799503